The insider buying is too small to signal a material conviction call. The guidance cut and restructuring charges are the dominant narrative. Monitor for larger insider purchases or any 8-K filings on restructuring execution. The stock's reaction to the earnings/guidance news over the next 2-4 weeks will be more informative than these director purchases.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 6 $49.30entry
- T+1 · 3mo ago +0.02%α −0.59% · $49.31
- T+5 · 3mo ago +4.85%α +3.64% · $51.69
- T+20 · 2mo ago −4.77%α −5.37% · $46.95
- T+60 · 17d ago −14.85%α −13.18% · $41.98
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Boston Scientific directors made open-market purchases totaling $277K in the week following the company's Q2 earnings report, which beat consensus but included a significant full-year guidance cut and a $700M-$800M restructuring plan. The insider buying is modest relative to the $69.2B market cap (0.0004%), but the timing, post-earnings and post-restructuring announcement, suggests directors see value at current levels despite the operational headwinds.
Key Financial Metrics
Key Facts
- Director Edward Ludwig purchased 5,000 shares at $45.48 for $227K on July 31.
- Director David Habiger purchased 1,042 shares at $48.07 for $50K on Aug 3.
- Total insider buying of $277K represents ~0.0004% of BSX's $69.2B market cap.
- Purchases occurred 2-5 days after Q2 earnings beat but guidance cut and restructuring announcement.
- EVP Fitzgerald Joseph's $3M discretionary transaction on July 31 is not an open-market buy/sell and is excluded from net direction.
Financial Impact
Insider purchases of $277K are trivial relative to $69.2B market cap (0.0004%).
Risk Factors
- Insider buying is de minimis relative to market cap and may be routine portfolio rebalancing.
- Guidance cut and $700M-$800M restructuring charges signal fundamental deceleration.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BSX-1786003781263 |
Track record
22 reports on BSX
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.
Filters
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
- Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
- Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
- Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
- Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers